+14,546.7%
NVDA vs EMR
+284.0%
+14,262.7%
-66.3%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | EMR | Excess | Alpha |
|---|---|---|---|---|
| 1D | 0.0% | +2.6% | -2.6% | -1.7% |
| 7D | -5.1% | -0.4% | -4.7% | -4.9% |
| 30D | -2.5% | -6.8% | +4.3% | +1.9% |
| 3M | +6.7% | +7.5% | -0.8% | +1.1% |
| 6M | +17.6% | +9.9% | +7.8% | +8.9% |
| YTD | +17.3% | +16.0% | +1.4% | +3.3% |
| 1Y | +23.5% | +12.4% | +11.1% | +10.5% |
| 3Y | +384.6% | +60.2% | +324.4% | +236.9% |
| 5Y | +875.4% | +67.9% | +807.5% | +560.3% |
| All | +14,546.7% | +284.0% | +14,262.7% | +6,214.2% |
Cumulative growth
Daily Returns
Daily percentage return beside EMR.
Daily Out/Under-Performance
Portfolio return minus EMR return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × EMR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded EMR wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling